Sequential versus concomitant chemotherapy and tamoxifen in breast cancer
This article has no abstract so we have provided the first paragraph of the full text.
Chemotherapy is generally administered before hormone therapy in patients with endocrine-responsive breast cancer, but there is a paucity of data to indicate that long-term outcomes are better with this regimen than if the two therapies are administered concomitantly.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.